The Kuopio University Hospital offers access to clinical research with 800 hospital beds and over 5000 medical professionals, which dramatically cuts development and testing time for pharmaceuticals and medical technology solutions.
Companies within the clinical research cluster include the following: Medfiles, offering clinical research services (acquired by Japanese WDB Holdings); Charles River Laboratories, offering pre-clinical services; and smaller SME companies, providing niche services for drug and medical devices development. A Clinical Research Centre – CRC in UEF/Kuopio Campus focuses its clinical research on the diagnosis, treatment and prevention on nationally important chronic diseases, e.g., neurological diseases, diabetes, vascular diseases, obesity, and diseases of bone and cartilage. It works in close collaboration with the Kuopio University Hospital.
Clinical research talents and availability of extensive clinical data (data lake) have created beneficial partnerships between global pharma companies like Roche and MSD with clinical research partners in Kuopio. UEF, KUH, and local companies offer clinical research services along with education services for healthcare professionals, for a better understanding of the treatment of diseases and development of new therapies. Contract research companies (CROs) in Kuopio provide support to the pharmaceutical, biotechnology, and medical device industries in the form of research services outsourced on a contract basis.
“Critical mass of researchers and university hospital was important factor in the placement of Neurocenter. But it is not enough to have world class research. There must also be communal support and ecosystems. The city of Kuopio has seen the potential of the Neurocenter and their support for creating an ecosystem has been very important for our success.”